AI-enabled Cardiac Chambers Volumetry and Calcified Plaque Characterization in Coronary Artery Calcium (CAC) Scans (AI-CAC) Significantly Improves on Agatston CAC Score for Predicting All Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
Journal
Research square
ISSN: 2693-5015
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035
Informations de publication
Date de publication:
20 Jun 2024
20 Jun 2024
Historique:
pubmed:
1
7
2024
medline:
1
7
2024
entrez:
1
7
2024
Statut:
epublish
Résumé
Coronary artery calcium (CAC) scans contain valuable information beyond the Agatston Score which is currently reported for predicting coronary heart disease (CHD) only. We examined whether new artificial intelligence (AI) algorithms applied to CAC scans may provide significant improvement in prediction of all cardiovascular disease (CVD) events in addition to CHD, including heart failure, atrial fibrillation, stroke, resuscitated cardiac arrest, and all CVD-related deaths. We applied AI-enabled automated cardiac chambers volumetry and automated calcified plaque characterization to CAC scans (AI-CAC) of 5830 individuals (52.2% women, age 61.7±10.2 years) without known CVD that were previously obtained for CAC scoring at the baseline examination of the Multi-Ethnic Study of Atherosclerosis (MESA). We used 15-year outcomes data and assessed discrimination using the time-dependent area under the curve (AUC) for AI-CAC versus the Agatston Score. During 15 years of follow-up, 1773 CVD events accrued. The AUC at 1-, 5-, 10-, and 15-year follow up for AI-CAC vs Agatston Score was (0.784 vs 0.701), (0.771 vs. 0.709), (0.789 vs.0.712) and (0.816 vs. 0.729) (p<0.0001 for all), respectively. The category-free Net Reclassification Index of AI-CAC vs. Agatston Score at 1-, 5-, 10-, and 15-year follow up was 0.31, 0.24, 0.29 and 0.29 (p<.0001 for all), respectively. AI-CAC plaque characteristics including number, location, and density of plaque plus number of vessels significantly improved NRI for CAC 1-100 cohort vs. Agatston Score (0.342). In this multi-ethnic longitudinal population study, AI-CAC significantly and consistently improved the prediction of all CVD events over 15 years compared with the Agatston score.
Sections du résumé
Background
UNASSIGNED
Coronary artery calcium (CAC) scans contain valuable information beyond the Agatston Score which is currently reported for predicting coronary heart disease (CHD) only. We examined whether new artificial intelligence (AI) algorithms applied to CAC scans may provide significant improvement in prediction of all cardiovascular disease (CVD) events in addition to CHD, including heart failure, atrial fibrillation, stroke, resuscitated cardiac arrest, and all CVD-related deaths.
Methods
UNASSIGNED
We applied AI-enabled automated cardiac chambers volumetry and automated calcified plaque characterization to CAC scans (AI-CAC) of 5830 individuals (52.2% women, age 61.7±10.2 years) without known CVD that were previously obtained for CAC scoring at the baseline examination of the Multi-Ethnic Study of Atherosclerosis (MESA). We used 15-year outcomes data and assessed discrimination using the time-dependent area under the curve (AUC) for AI-CAC versus the Agatston Score.
Results
UNASSIGNED
During 15 years of follow-up, 1773 CVD events accrued. The AUC at 1-, 5-, 10-, and 15-year follow up for AI-CAC vs Agatston Score was (0.784 vs 0.701), (0.771 vs. 0.709), (0.789 vs.0.712) and (0.816 vs. 0.729) (p<0.0001 for all), respectively. The category-free Net Reclassification Index of AI-CAC vs. Agatston Score at 1-, 5-, 10-, and 15-year follow up was 0.31, 0.24, 0.29 and 0.29 (p<.0001 for all), respectively. AI-CAC plaque characteristics including number, location, and density of plaque plus number of vessels significantly improved NRI for CAC 1-100 cohort vs. Agatston Score (0.342).
Conclusion
UNASSIGNED
In this multi-ethnic longitudinal population study, AI-CAC significantly and consistently improved the prediction of all CVD events over 15 years compared with the Agatston score.
Identifiants
pubmed: 38947043
doi: 10.21203/rs.3.rs-4433105/v1
pmc: PMC11213177
pii:
doi:
Types de publication
Journal Article
Preprint
Langues
eng
Subventions
Organisme : NHLBI NIH HHS
ID : 75N92020D00005
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95160
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95163
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001079
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95164
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95168
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95165
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92020D00007
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95167
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000040
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92020D00002
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92020D00001
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95169
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95162
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92020D00003
Pays : United States
Organisme : NIAMS NIH HHS
ID : R42 AR070713
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95159
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146666
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95161
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001420
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92020D00004
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92020D00006
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC95166
Pays : United States
Références
J Cardiovasc Comput Tomogr. 2016 Nov - Dec;10(6):500-506
pubmed: 27499493
JAMA Cardiol. 2022 Feb 1;7(2):219-224
pubmed: 34613362
Eur Heart J Cardiovasc Imaging. 2014 Aug;15(8):863-9
pubmed: 24497517
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350
pubmed: 30423393
J Am Heart Assoc. 2018 Nov 20;7(22):e009476
pubmed: 30571498
J Cardiovasc Comput Tomogr. 2024 Jul-Aug;18(4):383-391
pubmed: 38653606
Radiology. 2005 Aug;236(2):477-84
pubmed: 15972340
Radiology. 2005 Jan;234(1):35-43
pubmed: 15618373
Radiol Artif Intell. 2023 Jul 05;5(5):e230024
pubmed: 37795137
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12
pubmed: 17569110
Am J Cardiol. 2002 Aug 1;90(3):254-8
pubmed: 12127613
J Comput Assist Tomogr. 2008 Nov-Dec;32(6):934-41
pubmed: 19204458
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
Stat Med. 2011 May 10;30(10):1105-17
pubmed: 21484848
JAMA. 2014 Jan 15;311(3):271-8
pubmed: 24247483
Int J Cardiol. 2014 Jun 15;174(2):318-23
pubmed: 24768385
J Clin Lipidol. 2022 Jan-Feb;16(1):66-74
pubmed: 34922882
Am J Epidemiol. 2002 Nov 1;156(9):871-81
pubmed: 12397006
BMC Med Res Methodol. 2017 Apr 7;17(1):53
pubmed: 28388943
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
Nat Methods. 2021 Feb;18(2):203-211
pubmed: 33288961
Acta Radiol. 2015 Aug;56(8):933-42
pubmed: 25033994
J Cardiovasc Comput Tomogr. 2024 Jul-Aug;18(4):392-400
pubmed: 38664073
Acta Radiol. 2014 Oct;55(8):917-25
pubmed: 24113145
Radiology. 2023 Apr;307(1):e221263
pubmed: 36511806
J Cardiovasc Comput Tomogr. 2015 Mar-Apr;9(2):113-9
pubmed: 25819193
World J Radiol. 2016 Dec 28;8(12):902-915
pubmed: 28070242
JACC Cardiovasc Imaging. 2016 Oct;9(10):1177-1185
pubmed: 27450878
J Cardiovasc Comput Tomogr. 2022 Mar-Apr;16(2):182-185
pubmed: 34657819
JACC Cardiovasc Imaging. 2024 Jul;17(7):780-791
pubmed: 38456877